In this article, Michael Corcoran and James Lawford Davies
discuss the firm's participation in Longevity Week and the
longevity sector in general.
Longevity Week aims to connect investor audiences with founders,
scientists and business leaders within the growing field of
regenerative medicine. This year, remote and virtual sessions have
enabled global life science companies to discuss major developments
in longevity and pitch their ideas for sustainable investment.
In the firm's continued support of Longevity Week, Hill
Dickinson recently participated in a Master Investor roundtable
discussing key industry progression. James Lawford Davies, a
partner in our life sciences and healthtech team, joined notable
thought leaders such as Phil Newman, Eric Verdin and Polina
Mamoshina to explore a challenging yet rewarding year in the
emerging space.